EP2085474A4 - Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector - Google Patents

Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector

Info

Publication number
EP2085474A4
EP2085474A4 EP07829087A EP07829087A EP2085474A4 EP 2085474 A4 EP2085474 A4 EP 2085474A4 EP 07829087 A EP07829087 A EP 07829087A EP 07829087 A EP07829087 A EP 07829087A EP 2085474 A4 EP2085474 A4 EP 2085474A4
Authority
EP
European Patent Office
Prior art keywords
hla
precursor
same
dna fragment
recombinant vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07829087A
Other languages
German (de)
French (fr)
Other versions
EP2085474A1 (en
Inventor
Tomoya Miyakawa
Keiko Udaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyushu University NUC
Kochi University NUC
NEC Corp
Original Assignee
Kyushu University NUC
Kochi University NUC
NEC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyushu University NUC, Kochi University NUC, NEC Corp filed Critical Kyushu University NUC
Priority to EP11193415.4A priority Critical patent/EP2434014B1/en
Publication of EP2085474A1 publication Critical patent/EP2085474A1/en
Publication of EP2085474A4 publication Critical patent/EP2085474A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
EP07829087A 2006-10-12 2007-10-03 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector Withdrawn EP2085474A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11193415.4A EP2434014B1 (en) 2006-10-12 2007-10-03 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006279232 2006-10-12
JP2007189047 2007-07-20
PCT/JP2007/069348 WO2008044567A1 (en) 2006-10-12 2007-10-03 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP11193415.4A Division EP2434014B1 (en) 2006-10-12 2007-10-03 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same

Publications (2)

Publication Number Publication Date
EP2085474A1 EP2085474A1 (en) 2009-08-05
EP2085474A4 true EP2085474A4 (en) 2010-12-01

Family

ID=39282776

Family Applications (2)

Application Number Title Priority Date Filing Date
EP11193415.4A Not-in-force EP2434014B1 (en) 2006-10-12 2007-10-03 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
EP07829087A Withdrawn EP2085474A4 (en) 2006-10-12 2007-10-03 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP11193415.4A Not-in-force EP2434014B1 (en) 2006-10-12 2007-10-03 HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same

Country Status (4)

Country Link
US (1) US8324345B2 (en)
EP (2) EP2434014B1 (en)
JP (2) JPWO2008044567A1 (en)
WO (1) WO2008044567A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4475469B2 (en) 2005-01-25 2010-06-09 日本電気株式会社 HLA-binding peptide, DNA fragment encoding it and recombinant vector
CA2860226C (en) 2011-12-22 2022-10-18 Randolph S. Watnick Saposin-a derived peptides and uses thereof
CN103965288B (en) * 2013-02-06 2016-12-28 温州医学院 Dengue virus specificity HLA-A*2402 restricted epitope peptide and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824506A (en) * 1994-08-15 1998-10-20 Genelabs Diagnostics Pte. Ltd. Dengue virus peptides and methods
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888512A (en) 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5723128A (en) 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
JP3616397B2 (en) 1992-05-26 2005-02-02 リュクスウニヴェルシテート レイデン Induction of antigen-specific T lymphocyte reaction
WO1994003205A1 (en) 1992-08-07 1994-02-17 Cytel Corporation Hla binding peptides and their uses
AU695261B2 (en) 1993-02-26 1998-08-13 Scripps Research Institute, The Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
CN1118572A (en) 1993-03-05 1996-03-13 萨依特尔有限公司 HLA-A2.1 combined peptide and application of same
JPH08151396A (en) 1994-11-28 1996-06-11 Teijin Ltd Hla-binding oligopeptide and immunomodulating agent containing the compound
EP0914142B9 (en) 1996-03-11 2012-01-04 Epimmune Inc. Peptides with increased binding affinity for at least three hla-a3-like molecules
JPH10298198A (en) 1997-04-22 1998-11-10 Takara Shuzo Co Ltd Antigen peptide for inducing ctl
AU748250B2 (en) 1997-12-05 2002-05-30 Kyogo Itoh Tumor antigen peptide derivatives
JPH11316754A (en) * 1998-05-06 1999-11-16 Nec Corp Experimental design and recording medium recording experimental design program
JP4138073B2 (en) 1998-05-08 2008-08-20 株式会社グリーンペプタイド Human cancer regression antigen protein
JP2000116383A (en) 1998-10-14 2000-04-25 Kyogo Ito Human cancer regression antigen protein
FR2798140B1 (en) * 1999-09-03 2003-04-11 Ifremer ENZYMATIC OYSTER HYDROLYSATES AND THEIR APPLICATIONS
AU2002305028A1 (en) * 2001-02-28 2002-10-28 Brown University Research Foundation West nile virus epitopes and uses thereof
JP4039483B2 (en) 2002-09-09 2008-01-30 愛知県 CD8 + cytotoxic T lymphocyte mHA epitope peptide and use thereof
JP2004154069A (en) 2002-11-07 2004-06-03 Japan Science & Technology Agency Modified endoglycosidase and anti-dengue virus agent
US7459297B2 (en) * 2003-05-30 2008-12-02 Centre National De La Recherche Scientifique -Cnrs Active truncated form of the RNA polymerase of flavivirus
JP4602006B2 (en) 2004-06-29 2010-12-22 独立行政法人科学技術振興機構 Survivin-derived HLA-A24 binding cancer antigen peptide
JP2006279232A (en) 2005-03-28 2006-10-12 Fuji Xerox Co Ltd Image reading apparatus and image processing method
JP2007189047A (en) 2006-01-13 2007-07-26 Seiko Epson Corp Method and device for connecting wiring board, mounting structure and electronic apparatus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US5824506A (en) * 1994-08-15 1998-10-20 Genelabs Diagnostics Pte. Ltd. Dengue virus peptides and methods

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BASHYAM HEMA S ET AL: "Dengue virus-reactive CD8(+) T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes", JOURNAL OF IMMUNOLOGY, vol. 176, no. 5, March 2006 (2006-03-01), pages 2817 - 2824, XP002605784, ISSN: 0022-1767 *
BECKER YECHIEL: "Computer simulations to predict the availability of peptides with known HLA class I motifs generated by proteolysis of Dengue fever virus (DFV) type 1 structural and nonstructural proteins in infected cells", VIRUS GENES, KLUWER ACADEMIC PUBLISHERS, BOSTON, US LNKD- DOI:10.1007/BF01701808, vol. 10, no. 3, 1 October 1995 (1995-10-01), pages 195 - 203, XP008128018, ISSN: 0920-8569 *
HUGHES A L: "Evolutionary change of predicted cytotoxic T cell epitopes of dengue virus.", INFECTION, GENETICS AND EVOLUTION : JOURNAL OF MOLECULAR EPIDEMIOLOGY AND EVOLUTIONARY GENETICS IN INFECTIOUS DISEASES DEC 2001 LNKD- PUBMED:12798027, vol. 1, no. 2, December 2001 (2001-12-01), pages 123 - 130, XP002605788, ISSN: 1567-1348 *
KURANE ICHIRO ET AL: "Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype cross-reactive human CD4-positive CD8-negative cytotoxic T-cell clone", JOURNAL OF VIROLOGY, vol. 67, no. 10, 1993, pages 6285 - 6288, XP002605789, ISSN: 0022-538X *
LARSEN METTE VOLDBY ET AL: "An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 35, no. 8, August 2005 (2005-08-01), pages 2295 - 2303, XP002605787, ISSN: 0014-2980 *
LOKE HSIN ET AL: "Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: A double-edged sword?", JOURNAL OF INFECTIOUS DISEASES, vol. 184, no. 11, 1 December 2001 (2001-12-01), pages 1369 - 1373, XP002605786, ISSN: 0022-1899 *
MONGKOLSAPAYA JUTHATHIP ET AL: "T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 MAR 2006 LNKD- PUBMED:16517753, vol. 176, no. 6, 15 March 2006 (2006-03-15), pages 3821 - 3829, XP002605785, ISSN: 0022-1767 *
ZHANG G L ET AL: "MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB LNKD- DOI:10.1093/NAR/GKI452, vol. 33, 1 January 2005 (2005-01-01), pages W172 - W179, XP003022704, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
EP2434014A1 (en) 2012-03-28
US8324345B2 (en) 2012-12-04
JP2013078325A (en) 2013-05-02
EP2085474A1 (en) 2009-08-05
WO2008044567A1 (en) 2008-04-17
JPWO2008044567A1 (en) 2010-02-12
US20100144025A1 (en) 2010-06-10
EP2434014B1 (en) 2014-12-10

Similar Documents

Publication Publication Date Title
IL184428A0 (en) Peptides with neuropeptide-2-receptor
EP2049569A4 (en) Hemagglutinin polypeptides, and reagents and methods relating thereto
GB0508863D0 (en) Peptide
EP1976864A4 (en) Novel peptide and use thereof
EP1858537A4 (en) Prion-specific peptide reagents
EP1858914A4 (en) Peptide networks
IL184284A0 (en) Modified beta thymosin peptides
IL185308A0 (en) Replikin peptides and uses thereof
IL207648A0 (en) Polypeptide having glyoxalase iii activity, polynucleotied encoding the same and uses thereof
AP2415A (en) Bacteriocin Inducer peptides.
EP1860184A4 (en) Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide
GB0604187D0 (en) Peptide and uses thereof
EP2099467A4 (en) Atap peptides, nucleic acids encoding the same and associated methods of use
EP2189531A4 (en) Novel dna fragment, recombinant vector containing the same, transformant transformed therewith and utilization of the same
EP2085474A4 (en) Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
IL196292A0 (en) Csf3r polypeptides, their preparation and uses thereof
GB0516527D0 (en) Peptides
ZA200807552B (en) Recombinant mononegaviral virus vectors
EP2021363A4 (en) Polypeptides and polynucleotides encoding the same
GB0521490D0 (en) RFamide-related peptide precursor proteins and RFamide peptides
PL380105A1 (en) Protein, its fragment and their applications
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0508726D0 (en) Polypeptide, vaccine and use thereof
GB0512422D0 (en) New polypeptide, uses thereof and methods employing it
GB0512550D0 (en) New polypeptide, uses thereof and methods employing it

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090512

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20101102

17Q First examination report despatched

Effective date: 20101115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111228